Cefuroxime axetil: an updated review of its use in the management of bacterial infections (Q34370476)

1 August 2017

1 reference

title

Cefuroxime axetil: an updated review of its use in the management of bacterial infections (English)

1 reference

1 August 2017

L J Scott

1

1 reference

1 August 2017

D Ormrod

series ordinal

2

1 reference

1 August 2017

K L Goa

series ordinal

3

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

61

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1455-1500

1 reference

Cefuroxime: human pharmacokinetics

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161100-00008

Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161100-00008

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161100-00008

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161100-00008

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200161100-00008

Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections

21 January 2018

1 reference

12 December 2020

Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)

1 reference

12 December 2020

Cefuroxime concentrations in serum, joint fluid and bone in elderly patients undergoing arthroplasty after administration of cefuroxime axetil

1 reference

12 December 2020

Clinical pharmacokinetics of oral cephalosporins

1 reference

12 December 2020

Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women.

1 reference

12 December 2020

Short-course antibiotic therapy for infections with a single causative pathogen.

1 reference

12 December 2020

Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children

1 reference

12 December 2020

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

12 December 2020

Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis

1 reference

12 December 2020

Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis

1 reference

12 December 2020

Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.

1 reference

12 December 2020

Cefuroxime axetil in the treatment of cutaneous infections

1 reference

12 December 2020

Otitis media: focus on antimicrobial resistance and new treatment options

1 reference

12 December 2020

Penicillin-binding protein-mediated resistance in pneumococci and staphylococci

1 reference

12 December 2020

Concentration of cefuroxime in middle ear effusion of children with acute otitis media.

1 reference

12 December 2020

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

12 December 2020

Acute otitis media: management and surveillance in an era of pneumococcal resistance. Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group

1 reference

12 December 2020

Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study

1 reference

12 December 2020

Evaluation of cefuroxime axetil and cefadroxil suspensions for treatment of pediatric skin infections

1 reference

12 December 2020

Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis

1 reference

12 December 2020

Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae

1 reference

12 December 2020

A double-blind taste comparison of pediatric antibiotic suspensions

1 reference

12 December 2020

In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.

1 reference

12 December 2020

Cefuroxime axetil for treatment of uncomplicated gonorrhea

1 reference

12 December 2020

Fundamental basis for rational therapeutics in acute otitis media

1 reference

12 December 2020

Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections

1 reference

12 December 2020

Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections

1 reference

12 December 2020

Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study

1 reference

12 December 2020

Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin).

1 reference

12 December 2020

Comparative study of cefuroxime axetil and procaine penicillin in the treatment of uncomplicated gonorrhoea

1 reference

12 December 2020

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

1 reference

12 December 2020

Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime

1 reference

12 December 2020

Penetration of cefuroxime into chronically inflamed sinus mucosa.

1 reference

12 December 2020

Treatment of acute otitis media in an era of increasing microbial resistance.

1 reference

12 December 2020

Can antimicrobial activity be sustained? An appraisal of orally administered drugs used for respiratory tract infections

1 reference

12 December 2020

Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy

1 reference

12 December 2020

Penetration of cefuroxime into bronchial mucosa following oral administration of cefuroxime axetil

1 reference

12 December 2020

Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group

1 reference

12 December 2020

Clinical Comparison of Cefuroxime Axetil, Cephalexin and Cefadroxil in the Treatment of Patients with Primary Infections of the Skin or Skin Structures

1 reference

12 December 2020

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia

1 reference

12 December 2020

Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion

1 reference

12 December 2020

Clinical Comparison of Cefuroxime Axetil with Cefixime in the Treatment of Acute Bronchitis

1 reference

12 December 2020

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

12 December 2020

Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis

1 reference

12 December 2020

Antipneumococcal activities of gemifloxacin compared to those of nine other agents

1 reference

12 December 2020

International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.

1 reference

12 December 2020

Clinical comparison of single-oral-dose cefuroxime axetil and amoxicillin with probenecid for uncomplicated gonococcal infections in women

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of two oral forms of cefuroxime axetil

1 reference

12 December 2020

An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia

1 reference

12 December 2020

Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study

1 reference

12 December 2020

Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project

1 reference

12 December 2020

Penetration of oral cefuroxime axetil into the human aqueous humor.

1 reference

12 December 2020

Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

1 reference

12 December 2020

A multicenter trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults

1 reference

12 December 2020

Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods

1 reference

12 December 2020

Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998

1 reference

12 December 2020

Cefuroxime axetil in the treatment of acute otitis media in children

1 reference

12 December 2020

An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres

1 reference

12 December 2020

Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis

1 reference

12 December 2020

Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy

1 reference

12 December 2020

Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media

1 reference

12 December 2020

Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group

1 reference

12 December 2020

Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil

1 reference

12 December 2020

Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections

1 reference

12 December 2020

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

12 December 2020

A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions.

1 reference

12 December 2020

Comparative study of cefuroxime axetil suspension and amoxycillin syrup in the treatment of acute otitis media in general practice.

1 reference

12 December 2020

Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains

1 reference

12 December 2020

Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis

1 reference

12 December 2020

Comparative efficacy and tolerability of cephradine and cefuroxime axetil in the treatment of acute dysuria and/or frequency in general practice

1 reference

12 December 2020

Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis.

1 reference

12 December 2020

Is oral cefuroxime axetil suitable for the treatment of unidentified bacterial infection of skin and soft tissue?

1 reference

12 December 2020

Cefuroxime resistance in Klebsiella pneumoniae. Susceptibility to cefotaxime and ceftazidime despite production of ESBLs

1 reference

12 December 2020

Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.

1 reference

12 December 2020

Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis

1 reference

12 December 2020

Acute otitis media: part II. Treatment in an era of increasing antibiotic resistance

1 reference

12 December 2020

Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

1 reference

12 December 2020

Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function

1 reference

12 December 2020

Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children

1 reference

12 December 2020

How short can courses be in lower respiratory tract infections?

1 reference

12 December 2020

In vitro study of the post-antibiotic effect and the bactericidal activity of Cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens

1 reference

12 December 2020

Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy.

1 reference

12 December 2020

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

1 reference

12 December 2020

Group A beta-haemolytic streptococcal (GABHS) tonsillopharyngitis is still a common problem

1 reference

12 December 2020

Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children

1 reference

12 December 2020

Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil

1 reference

12 December 2020

Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin

1 reference

12 December 2020

A multicenter, randomized, single-blind evaluation of cefuroxime axetil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

1 reference

12 December 2020

Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens

1 reference

12 December 2020

Cefuroxime axetil vs. augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease

1 reference

12 December 2020

Controversies in the medical management of persistent and recurrent acute otitis media. Recommendations of a clinical advisory committee.

1 reference

12 December 2020

Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group

1 reference

12 December 2020

Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group

1 reference

12 December 2020

Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group

1 reference

12 December 2020

Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy.

1 reference

12 December 2020

Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens

1 reference

12 December 2020

Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)

1 reference

12 December 2020

Prescribing antimicrobial agents for treatment of acute otitis media

1 reference

12 December 2020

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998

1 reference

12 December 2020

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

12 December 2020

[Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults. Comparative study with cefaclor]

1 reference

12 December 2020

Cefuroxime axetil to treat gonorrhea

1 reference

12 December 2020

1 reference

12 December 2020

[Pharmacokinetics of cefuroxime-axetil administered by the oral route in the elderly]

1 reference

12 December 2020

Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate.

1 reference

12 December 2020

Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis

1 reference

12 December 2020

In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998

1 reference

12 December 2020

Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.

1 reference

12 December 2020

Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.

1 reference

12 December 2020

Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis

1 reference

12 December 2020

ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society

1 reference

12 December 2020

Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia

1 reference

12 December 2020

Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans

1 reference

12 December 2020

Effect of dose and food on the bioavailability of cefuroxime axetil.

1 reference

12 December 2020

Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.

1 reference

12 December 2020

Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group

1 reference

12 December 2020

An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue

1 reference

12 December 2020

Serum bactericidal activity of newer oral cephalosporins in healthy volunteers

1 reference

12 December 2020

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

1 reference

12 December 2020

Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacteri

1 reference

12 December 2020

Choosing an antibiotic on the basis of pharmacodynamics.

1 reference

12 December 2020

Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis

1 reference

12 December 2020

Cefuroxime resistance in Escherichia coli. Resistance mechanisms and prevalence.

1 reference

12 December 2020

Update on acute otitis media

1 reference

12 December 2020

Comparative clinical efficacy of single oral doses of cefuroxime axetil and amoxicillin in uncomplicated gonococcal infections

1 reference

12 December 2020

A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group

1 reference

12 December 2020

Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice

1 reference

12 December 2020

Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program

1 reference

12 December 2020

Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Sinus and Allergy Health Partnership

1 reference

12 December 2020

Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: a controlled trial

1 reference

12 December 2020

Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea

1 reference

12 December 2020

Rheumatic fever--is it still a problem?

1 reference

12 December 2020

Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study

1 reference

12 December 2020

Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children

1 reference

12 December 2020

10.2165/00003495-200161100-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1047762591

0 references

1 reference